Jiangxi Fushine Pharmaceutical Co Ltd
Jiangxi Fushine Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers ß-lactamase inhibitors, carbapenem antibiotics, and antiviral drug intermediates; argatroban injection for the treatment of acute ischemic stroke; and doxycycline hydrochloride… Read more
Jiangxi Fushine Pharmaceutical Co Ltd (300497) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.008x
Based on the latest financial reports, Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a cash flow conversion efficiency ratio of 0.008x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.31 Million) by net assets (CN¥2.17 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jiangxi Fushine Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Jiangxi Fushine Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jiangxi Fushine Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangxi Fushine Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hongta Securities Co Ltd
SHG:601236
|
0.070x |
|
Thai Union Group PCL
BK:TU
|
-0.029x |
|
National Beverage Corp
NASDAQ:FIZZ
|
0.047x |
|
Viad Corp
NYSE:VVI
|
0.569x |
|
Criteo Sa
NASDAQ:CRTO
|
0.136x |
|
Neuren Pharmaceuticals Limited
PINK:NURPF
|
0.397x |
|
Shanghai Emperor of Cleaning Hi-Tech Co Ltd
SHG:603200
|
0.010x |
|
Sichuan Chengfei Integration Technology Corp Ltd
SHE:002190
|
0.003x |
Annual Cash Flow Conversion Efficiency for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.18 Billion | CN¥187.64 Million | 0.086x | +428.84% |
| 2023-12-31 | CN¥2.47 Billion | CN¥-64.76 Million | -0.026x | +41.66% |
| 2022-12-31 | CN¥2.69 Billion | CN¥-120.85 Million | -0.045x | -280.87% |
| 2021-12-31 | CN¥2.91 Billion | CN¥72.32 Million | 0.025x | -80.20% |
| 2020-12-31 | CN¥3.05 Billion | CN¥382.35 Million | 0.125x | -43.29% |
| 2019-12-31 | CN¥1.53 Billion | CN¥337.91 Million | 0.221x | +44.20% |
| 2018-12-31 | CN¥1.15 Billion | CN¥175.91 Million | 0.153x | -29.62% |
| 2017-12-31 | CN¥966.71 Million | CN¥210.72 Million | 0.218x | -9.34% |
| 2016-12-31 | CN¥784.17 Million | CN¥188.53 Million | 0.240x | +93.69% |
| 2015-12-31 | CN¥596.21 Million | CN¥74.01 Million | 0.124x | +12.02% |
| 2014-12-31 | CN¥283.26 Million | CN¥31.39 Million | 0.111x | -55.50% |
| 2013-12-31 | CN¥229.76 Million | CN¥57.22 Million | 0.249x | -27.25% |
| 2012-12-31 | CN¥184.60 Million | CN¥63.20 Million | 0.342x | +22.08% |
| 2011-12-31 | CN¥120.52 Million | CN¥33.80 Million | 0.280x | -- |